Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Qilu Pharmaceutical Research And Development Center Ltd

Clinical trials sponsored by Shanghai Qilu Pharmaceutical Research And Development Center Ltd, explained in plain language.

Not yet recruiting 1

New hope for Hard-to-Treat cancers: QLS1317 enters human testing

Disease control Not yet recruiting

This early-phase study tests a new drug called QLS1317 in about 120 adults with advanced solid tumors that have high microsatellite instability (MSI-H) or a DNA repair defect (dMMR) and have stopped responding to standard treatments. The main goals are to find the safest dose and…

Phase: PHASE1 • Sponsor: Shanghai Qilu Pharmaceutical Research and Development Center LTD • Aim: Disease control

Last updated May 19, 2026 11:47 UTC